Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Titilayo Adeniyan

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 7, 2020
Biomarkers for Allogeneic HCT OutcomesDjamilatou Adom, Courtney Rowan, Titilayo Adeniyan, et al.
Science Translational Medicine|October 8, 2020
ICOSL<sup>+</sup> plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonistDjamilatou Adom, Stacey R Dillon, Jinfeng Yang, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 7, 2020
Biomarkers for Allogeneic HCT OutcomesDjamilatou Adom, Courtney Rowan, Titilayo Adeniyan, et al.
Science Translational Medicine|October 8, 2020
ICOSL<sup>+</sup> plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonistDjamilatou Adom, Stacey R Dillon, Jinfeng Yang, et al.
Pageof 1